$1.74 -0.04 (-2.25%)
11/27/2009 1:00 PM

AVANIR Pharmaceuticals (AVNR)

CAPS Rating: 2 out of 5

A pharmaceutical company focused on developing, acquiring and commercializing novel therapeutic products for the treatment of chronic diseases.

Featured Broker Partners